Correlation Between Vincerx Pharma and Opus Genetics,
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Opus Genetics,, you can compare the effects of market volatilities on Vincerx Pharma and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Opus Genetics,.
Diversification Opportunities for Vincerx Pharma and Opus Genetics,
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Vincerx and Opus is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Opus Genetics, go up and down completely randomly.
Pair Corralation between Vincerx Pharma and Opus Genetics,
Given the investment horizon of 90 days Vincerx Pharma is expected to generate 2.13 times more return on investment than Opus Genetics,. However, Vincerx Pharma is 2.13 times more volatile than Opus Genetics,. It trades about 0.0 of its potential returns per unit of risk. Opus Genetics, is currently generating about -0.06 per unit of risk. If you would invest 147.00 in Vincerx Pharma on September 12, 2024 and sell it today you would lose (126.00) from holding Vincerx Pharma or give up 85.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vincerx Pharma vs. Opus Genetics,
Performance |
| Timeline |
| Vincerx Pharma |
| Opus Genetics, |
Vincerx Pharma and Opus Genetics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vincerx Pharma and Opus Genetics,
The main advantage of trading using opposite Vincerx Pharma and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.| Vincerx Pharma vs. Spero Therapeutics | Vincerx Pharma vs. Bolt Biotherapeutics | Vincerx Pharma vs. Coherus BioSciences | Vincerx Pharma vs. Applied Therapeutics |
| Opus Genetics, vs. Anheuser Busch Inbev | Opus Genetics, vs. Universal | Opus Genetics, vs. Ispire Technology Common | Opus Genetics, vs. Philip Morris International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |